DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01582438 (ClinicalTrials.gov)	November 2012	19/4/2012	An Open Label Access Study For Subjects Who Completed A1481156	A Local, Multicentre, Open Label Access Study, To Provide Sildenafil Therapy For Subjects Who Completed A1481156 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil For Subjects In India	Pulmonary Arterial Hypertension	Drug: Access program - sildenafil citrate, Viagra, Revatio	Pfizer	NULL	No longer available	12 Years	30 Years	All		N/A	India

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01582438
(ClinicalTrials.gov)

November 2012

19/4/2012

An Open Label Access Study For Subjects Who Completed A1481156

A Local, Multicentre, Open Label Access Study, To Provide Sildenafil Therapy For Subjects Who Completed A1481156 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil For Subjects In India

Pulmonary Arterial Hypertension

Drug: Access program - sildenafil citrate, Viagra, Revatio

Pfizer

NULL

No longer available

12 Years

30 Years

All

N/A

India